Loading...
NPI 1093749087 · East Brunswick, NJ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Aculabs Inc is a clinical medical laboratory provider located in East Brunswick, New Jersey. This profile covers 126 Medicare and 121 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Aculabs Inc |
| Address | 2 Kennedy Blvd |
| City | East Brunswick |
| State | NJ |
| ZIP | 08816 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 10, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $7.7M |
| Medicaid | $7.2M |
ACULABS INC appears to operate as a high-volume clinical laboratory with a significant outreach/homebound specimen-collection footprint. Medicare billing shows G0471 as the single largest Medicare line item: G0471 accounts for $1.6M revenue (23.7% of this provider's total Medicare revenue) and the provider ranks #3 of 117 nationally (98th percentile; extreme outlier), while travel-related codes P9603 (481.7K claims, $481.7K revenue, 7.1%) and P9604 (33.8K claims, $101.4K revenue, 1.5%) further signal extensive specimen pickup activity from SNFs and homebound patients under both Medicare and Medicaid billing patterns.
Revenue concentration is material for both payers. The platform’s precomputed measures show the top three Medicare codes account for 45.3% of Medicare revenue and the top three Medicaid codes account for 39.4% of Medicaid revenue, indicating that a relatively small set of tests and collection services drive a large share of revenue for each program.
Payer mix is balanced in scale: lifetime Medicare revenue is $7.7M while lifetime Medicaid revenue is $7.2M, so ACULABS bills both programs at similar total-dollar levels rather than being effectively single-payer. This near-parity implies contractual and operational exposure to both Medicare and state Medicaid reimbursement policies.
The CPT mix (85025, 80053, 80048 and multiple panel/chemistry and microbiology codes) signals a core business built on routine high-throughput laboratory testing. On Medicare the provider bills high volumes of 85025 (92.5K claims, $739.7K revenue, 10.9%) and 80053 (72.1K claims, $721.5K revenue, 10.7%), while on Medicaid 80053 (216.7K claims, $650K revenue, 10.6%) and 85025 (288K claims, $576.1K revenue, 9.4%) are also top generators — a pattern consistent with central lab processing of CBCs, CMPs/BMPs and panels.
Competitive standing differs by code and payer: the lab is a dominant national outlier for several Medicare codes but more mixed at the state level for Medicaid. Examples of national dominance include 85025 (ranks #39 of 32833, 100th percentile; extreme outlier) and 80053 (ranks #53 of 26416, 100th percentile; extreme outlier), while on Medicaid the provider is the state leader for P9604 (284K claims, $852.1K revenue, 13.9%; ranks #1 of 27 in-state, 100th percentile; extreme outlier) but more typical for U0003 (45.8K claims, $915.4K revenue, 14.9%; ranks #24 of 127 in-state, 82nd percentile; typical, unremarkable).
The provider shows a meaningful role in COVID-era molecular testing, particularly for Medicaid where U0003 is the top Medicaid code by revenue (45.8K claims, $915.4K revenue, 14.9%). Medicare COVID claims are present but smaller in absolute dollars (U0003: 4.2K claims, $311.5K revenue, 4.6%), indicating ACULABS scaled molecular testing for state Medicaid volumes more heavily than for Medicare during the measured window.
Several codes are flagged as statistical outliers, reinforcing that ACULABS operates at volumes far above typical peers for specific services. Notable labels in the file include 'extreme outlier' for Medicare G0471 and several core chemistry/hematology panels (e.g., 85025, 80053) and 'extreme outlier' for Medicaid P9604 (state leader), while a mix of other codes are described as 'notably above typical' or 'typical, unremarkable' depending on the test and payer. These labels corroborate that the provider is unusually concentrated in both collection/outreach services and routine, high-throughput lab testing.
The provider has a long active tenure in national enrollment: NPI enumerated 2006-07-10 (~20 years ago). That duration, combined with top-percentile rankings on multiple high-volume lab CPTs and travel/collection codes, suggests an established lab operation with sustained relationships that generate high specimen volumes from SNFs, homebound patients, and outpatient ordering clinicians.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
126 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 160,210 | $10 | $1.6M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 92,460 | $10 | $739.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 72,150 | $10 | $721.5K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 481,660 | $1 | $481.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 26,730 | $20 | $427.6K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 39,330 | $10 | $314.7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 4,210 | $70 | $311.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 9,860 | $30 | $285.9K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 19,260 | $10 | $250.3K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 18,630 | $10 | $186.3K |
Showing 1–10 of 126
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 126 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
126 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0471 | 1 | 10 | 25,620 | $10 | $699.5K |
| 87506 | 7 | 10 | 110 | $260 | $506.1K |
| P9603 | 2 | 10 | 11,620 | $1 | $245.2K |
| U0003 | 8 | 80 | 110 | $70 | $101.7K |
| 83880 | 6 | 50 | 70 | $40 | $83.4K |
| 82306 | 7 | 250 | 50 | $30 | $79K |
| 84443 | 6 | 380 | 100 | $20 | $65.5K |
| 80061 | 6 | 370 | 130 | $10 | $65.4K |
| 83970 | 7 | 120 | 60 | $40 | $54.3K |
| 80053 | 6 | 560 | 90 | $10 | $50.8K |
Showing 1–10 of 126
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
121 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 45,770 | $20 | $915.4K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 284,040 | $1 | $852.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 216,670 | $1 | $650K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 288,050 | $1 | $576.1K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 126,020 | $1 | $378.1K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 63,480 | $10 | $317.4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 37,980 | $10 | $303.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 54,780 | $10 | $273.9K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 23,750 | $10 | $237.5K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 5,720 | $40 | $228.9K |
Showing 1–10 of 121
How this provider's Medicaid billing volume and revenue compare to other New Jersey providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Jersey median
121 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 24 | 130 | 3,180 | $60 | $4.2M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 9 | 40 | 590 | $20 | $1.9M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 132 | 150 | 3,680 | $30 | $1.5M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 29 | 140 | 5,590 | $20 | $823.1K |
| 86769 | The lab analyst performs a multiple–step immunoassay to evaluate the patient’s serum for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), which causes coronavirus disease… | 22 | 60 | 280 | $40 | $728.3K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 58 | 70 | 510 | $10 | $610.7K |
| 86481 | The lab analyst performs a test to evaluate an antigen response to certain tuberculosis (TB) antibodies by enumerating T cells that produce gamma interferon. | 9 | 20 | 200 | $40 | $605.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 10 | 140 | 870 | $10 | $605.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 6 | 190 | 7,750 | $10 | $466.9K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 9 | 160 | 2,310 | $1 | $395.6K |
Showing 1–10 of 121
Other providers in the same ZIP code as Aculabs Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Apluscare, LLC | NJ | Community/Behavioral Health Agency | $0 | $54.7M |
| Their Place Inc. | NJ | Community/Behavioral Health Agency | $0 | $43.8M |
| University Radiology Group, LLC | NJ | Diagnostic Radiology Physician | $0 | $33.8M |
| Just Home Inc | NJ | Adult Day Care Clinic/Center | $0 | $21.9M |
| Catholic Charities, Diocese Of Metuchen | NJ | Community/Behavioral Health Agency | $0 | $13M |
| Osprey Home Health LLC | NJ | Home Health Agency | $0 | $7.8M |
| Allmed Transportation Inc | NJ | Ambulance | $6.9M | $831.6K |
| Specialized Surgical Center Of Central New Jersey, LLC | NJ | Ambulatory Surgical Clinic/Center | $2.3M | $678.3K |
| Ez Clinical Laboratory Inc | NJ | Clinical Medical Laboratory | $463.4K | $880.2K |
| Naveen Ahuja | NJ | Plastic Surgery Physician | $970.7K | $30.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.